Cargando…
High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS
Autores principales: | Bracaglia, C, Marafon, D Pires, Caiello, I, de Graaf, K, Guilhot, F, Ferlin, W, Davì, S, Schulert, G, Ravelli, A, Grom, A, Nelson, R, de Min, C, De Benedetti, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596995/ http://dx.doi.org/10.1186/1546-0096-13-S1-O84 |
Ejemplares similares
-
Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model
por: Bracaglia, Claudia, et al.
Publicado: (2014) -
Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis
por: Bracaglia, C, et al.
Publicado: (2015) -
Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis
por: Buatois, Vanessa, et al.
Publicado: (2017) -
IFN-γ is essential for alveolar macrophage–driven pulmonary inflammation in macrophage activation syndrome
por: Gao, Denny K., et al.
Publicado: (2021) -
Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019)